4.5 Article

Increased thromboinflammatory load in hereditary angioedema

Related references

Note: Only part of the references are listed.
Review Allergy

Therapeutic monoclonal antibodies with a focus on hereditary angioedema

Bruce L. Zuraw et al.

Summary: Monoclonal antibodies (mAbs) have shown efficacy and safety in various therapeutic areas. This article discusses the advantages and limitations of mAbs compared to small molecules and introduces a novel mAb for the treatment of hereditary angioedema (HAE), a rare and life-threatening condition characterized by recurrent swelling attacks. Lanadelumab, a fully human mAb targeting plasma kallikrein, has demonstrated promising results in clinical trials, including a pivotal Phase 3 study. It has the potential to provide an effective and less burdensome treatment option for HAE patients.

ALLERGOLOGY INTERNATIONAL (2023)

Article Medicine, General & Internal

Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Timothy J. Craig et al.

Summary: The study evaluated the efficacy and safety of monthly subcutaneous administrations of garadacimab for hereditary angioedema, finding a significant reduction in attacks compared to placebo in patients aged 12 years and older. The results support garadacimab as a potential prophylactic therapy for hereditary angioedema in adolescents and adults.

LANCET (2023)

Article Allergy

The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update

Marcus Maurer et al.

Summary: The revision and update of the guideline on the diagnosis and management of hereditary angioedema (HAE) provides up-to-date guidance for physicians and their patients. It aims to help make rational decisions in the management of HAE, including diagnostics, treatments, goals of treatment, management for special patient groups, and disease monitoring.

ALLERGY (2022)

Article Cell Biology

A modular map of Bradykinin-mediated inflammatory signaling network

D. A. B. Rex et al.

Summary: Bradykinin signals through its receptor B2R with diverse vascular permeability functions and is implicated in inflammation, chronic pain, vasculopathy, neuropathy, obesity, diabetes, and cancer. An integrated pathway reaction map of bradykinin consisting of 233 reactions has been developed, which will aid in identifying novel therapeutic targets for diseases associated with dysregulated bradykinin signaling.

JOURNAL OF CELL COMMUNICATION AND SIGNALING (2022)

Article Medicine, General & Internal

Inhibition of Prekallikrein for Hereditary Angioedema

Laure M. Fijen et al.

Summary: In this small phase 2 trial, donidalorsen treatment resulted in a significantly lower rate of angioedema attacks than placebo among patients with hereditary angioedema. The change in quality of life score was more significant in the donidalorsen group, with a relatively lower incidence of adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Allergy

Comorbidities in hereditary angioedema-A population-based cohort study

Linda Sundler Bjorkman et al.

Summary: Patients with hereditary angioedema (HAE) have increased risk of cardiovascular disease, hypertension, hyperlipidemia, and autoimmune diseases, but not cancer.

CLINICAL AND TRANSLATIONAL ALLERGY (2022)

Letter Hematology

Hereditary angioedema is associated with an increased risk of venous thromboembolism

Steven P. Grover et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Article Allergy

Novel hereditary angioedema linked with a heparan sulfate 3-O-sulfotransferase 6 gene mutation

Konrad Bork et al.

Summary: The study identified a novel disease-linked mutation for HAEnCI using whole exome sequencing, which affects HS biosynthesis and likely disrupts cell surface interactions of key players in angioedema formation.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Allergy

Biomarkers in Hereditary Angioedema

Grzegorz Porebski et al.

Summary: Biomarkers are defined characteristics used to measure normal, biological, pathogenic processes, or biological responses. Different types of biomarkers can be used for diagnosing diseases, monitoring medical conditions, checking biological responses, predicting patient responses, and assessing future clinical event likelihood. While HAE involves various molecules, there are currently limited biomarkers for its diagnosis, disease activity evaluation, and treatment.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2021)

Article Allergy

Pathways of Neutrophil Granulocyte Activation in Hereditary Angioedema with C1 Inhibitor Deficiency

Erika Kajdacsi et al.

Summary: Hereditary angioedema (HAE) with C1-inhibitor deficiency is a type of bradykinin-mediated angioedema, where patients show activation of neutrophil granulocytes during symptom-free periods and a further increase during attacks, indicating the potential important role of neutrophil granulocytes in the pathomechanism of HAE.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2021)

Review Medicine, General & Internal

The Genetics of Hereditary Angioedema: A Review

Rosa Santacroce et al.

Summary: Hereditary angioedema is a rare genetic disorder caused by mutations in the SERPING1 gene, with a new type of HAE without SERPING1 gene mutations also identified. Six different genes have been associated with nC1-INH-HAE. Future research focuses on genetic characterization and diagnostic applications using NGS technologies.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Allergy

Burden of Autoimmune Disorders Among Patients With Hereditary Angioedema in the United States

Raffi Tachdjian et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Article Medicine, General & Internal

Antisense Inhibition of Prekallikrein to Control Hereditary Angioedema

Danny M. Cohn et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, Research & Experimental

The complex alteration in the network of IL-17-type cytokines in patients with hereditary angioedema

Francesco Arcoleo et al.

CLINICAL AND EXPERIMENTAL MEDICINE (2018)

Review Hematology

Hereditary angioedema: the plasma contact system out of control

S. De Maat et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)

Letter Allergy

Cleaved kininogen as a biomarker for bradykinin release in hereditary angioedema

Zonne L. M. Hofman et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)

Article Biochemistry & Molecular Biology

The plasma contact system, a protease cascade at the nexus of inflammation, coagulation and immunity

Henri Weidmann et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)

Review Hematology

The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities

A. H. Schmaier

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)

Letter Medical Laboratory Technology

Upregulation of cytokines and IL-17 in patients with hereditary angioedema

Francesco Arcoleo et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2014)

Review Biochemistry & Molecular Biology

PDGF receptor signaling networks in normal and cancer cells

Jean-Baptiste Demoulin et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2014)

Article Biochemical Research Methods

Bradykinin analysis revived - A validated method for determination of its stable metabolite in whole blood by LC-MS/MS

Knut F. Seip et al.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2014)

Article Immunology

Lipopolysaccharide Stimulates Platelets through an IL-1β Autocrine Loop

G. Thomas Brown et al.

JOURNAL OF IMMUNOLOGY (2013)

Review Biochemistry & Molecular Biology

An international serum standard for application in assays to detect human complement activation products

Grethe Bergseth et al.

MOLECULAR IMMUNOLOGY (2013)

Review Immunology

Complement, interferon and lupus

Keith B. Elkon et al.

CURRENT OPINION IN IMMUNOLOGY (2012)

Review Microbiology

Into the Eye of the Cytokine Storm

Jennifer R. Tisoncik et al.

MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2012)

Meeting Abstract Allergy

Does The Severity And Frequency Of Hereditary Angioedema Attacks Change With Age? A Patient Perspective

M. Lunn

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)

Article Hematology

The origins of age-related proinflammatory state

L Ferrucci et al.

BLOOD (2005)

Article Biochemistry & Molecular Biology

Differential substrate and inhibitor profiles for human MASP-1 and MASP-2

JS Presanis et al.

MOLECULAR IMMUNOLOGY (2004)

Article Cardiac & Cardiovascular Systems

Thrombostatin, a bradykinin metabolite, reduces platelet activation in a model of arterial wall injury

AR Prieto et al.

CARDIOVASCULAR RESEARCH (2002)

Article Cardiac & Cardiovascular Systems

Bradykinin and des-Arg9-bradykinin metabolic pathways and kinetics of activation of human plasma

M Cyr et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2001)

Article Hematology

In vitro interaction of C1-inhibitor with thrombin

M Cugno et al.

BLOOD COAGULATION & FIBRINOLYSIS (2001)

Article Biochemistry & Molecular Biology

Bradykinin stimulates lung fibroblasts to release neutrophil and monocyte chemotactic activity

S Koyama et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2000)